Elamipretide, A Mitochondrial-Targeted Drug, For The Treatment Of Vision Loss In Dry Amd With High Risk Drusen: Results Of The Phase 1 Reclaim StudyMichael John Allingham,Priyatham S Mettu,Scott W CousinsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2019）引用 14|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
